We consider Pfizer's FDA-approved anti-COVID pill, the 5G threat to airlines, and the state of the supply chain. Read More
Katherine Beem didn’t always intend to write about money. She’s a classically trained pianist who graduated from university with a degree in archaeology and ancient Greek and Latin. However, in 2007 she began working in financial publishing. She particularly enjoys writing about stocks and the markets, as well as investing in art and antiques. (Apparently, unearthing ideas about investing isn’t such a bad career alternative!)
Her writing has been featured in Truth & Plenty, Independence Monthly, NICHE, AmericanStyle, AntiqueWeek, Investor Junkie, TheStreet.com, Sure Dividend and many others.
Analyst Articles
We consider the upcoming Matter smart home standard, big-name CES cancellations, and the new probe into Tesla's dashboard devices. Read More
We consider the economic effects on a no-go Build Back Better Act, Oracle's pricey attempt to stay relevant, and Pfizer's big bet on cannabis. Read More
We consider Yahoo Finance's picks for Best and Worst Companies of the Year, Microsoft and Meta, as well as the newest Ford EV taxis to hit NYC. Read More
We consider the impact of inflation on Build Back Better, the record-breaking weekend for Spider-Man, and the rise of cryptocurrency hacks. Read More
We consider the ransomware attack on Kronos, the Bank of England's decision to raise interest rates, and Kraft's attempt to make the most out of the cream cheese shortage. Read More
We examine slower retail sales growth in November, the sputtering DIY segment, and increasingly popular plastic surgery procedures. Read More
We consider Harley Davidson's new electric motorcycle company, how to play electric flight developments, and the computer chips that will power the Metaverse. Read More
We consider the rise of stock buybacks, Peloton's Sex and the City-fueled stock slump, and how Lego beats gold. Read More
We examine the latest CPI, household net wealth, and the decline of tobacco. Read More